Copyright
©The Author(s) 2023.
World J Hepatol. Apr 27, 2023; 15(4): 477-496
Published online Apr 27, 2023. doi: 10.4254/wjh.v15.i4.477
Published online Apr 27, 2023. doi: 10.4254/wjh.v15.i4.477
Figure 1 Summarizes the risk factors involved in the development of metabolic-associated fatty liver disease.
HDL: High-density lipoprotein; MAFLD: Metabolic-associated fatty liver disease.
Figure 2 Proposed diagnostic criteria for metabolic-associated fatty liver disease are outlined.
MAFLD: Metabolic-associated fatty liver disease; HDL: High-density lipoprotein.
- Citation: Alomari M, Rashid MU, Chadalavada P, Ragheb J, Zafar H, Suarez ZK, Khazaaleh S, Gonzalez AJ, Castro FJ. Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes. World J Hepatol 2023; 15(4): 477-496
- URL: https://www.wjgnet.com/1948-5182/full/v15/i4/477.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i4.477